Takeda Continues Divestiture Strategy with Sale of Select OTC and Non-Core Assets in Europe to Orifarm for up to approximately $670M USD Read more
Affinivax Announces $120 Million Series B Financing to Advance Pipeline of Novel MAPS Vaccines and Immunotherapies Read more
Catalent Biologics Completes $14 Million Commercial Packaging Expansion at its Bloomington, Indiana Facility Read more